As of Sep 28
| +0.01 / +0.18%|
The 5 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 13.00, with a high estimate of 40.00 and a low estimate of 7.00. The median estimate represents a +127.27% increase from the last price of 5.72.
The current consensus among 5 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.